Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-29

Clinical Trial Update: Sildenafil Efficacy Study on Time Walk From Peripheral Arterial Desease Patients (Stade II) With Arterial Claudication [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating sildenafil efficacy for time to walk in patients with peripheral arterial occlusive disease and arterial claudication; study c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: University Hospital, Angers | Conditions: Peripheral Arterial Occlusive Disease | Phase 3 | Status: COMPLETED